Point-of-Care Ultrasound Aids in the Management of Patient Taking Semaglutide Before Surgery: A Case Report

A A Pract. 2024 Mar 18;18(3):e01762. doi: 10.1213/XAA.0000000000001762. eCollection 2024 Mar 1.

Abstract

Semaglutide, a glucagon-like peptide-1 (GLP-1) analog, has various effects on the gastrointestinal tract. In patients undergoing anesthesia delayed gastric emptying time can have sequelae if not identified preoperatively. Modalities include thorough history regarding the last dose administration of a GLP-1 analog and ultrasound of gastric contents before induction of anesthesia. We present a case in which gastric ultrasound identified a patient at increased risk for aspiration on induction and allowed for appropriate alterations in the anesthetic plan.

Publication types

  • Case Reports

MeSH terms

  • Gastrointestinal Tract
  • Glucagon-Like Peptide 1*
  • Glucagon-Like Peptides*
  • Humans
  • Point-of-Care Systems*
  • Point-of-Care Testing

Substances

  • semaglutide
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptides